Literature DB >> 2947643

Protein S is a cofactor for activated protein C neutralization of an inhibitor of plasminogen activation released from platelets.

A D'Angelo, M S Lockhart, S V D'Angelo, F B Taylor.   

Abstract

Platelets stimulated with thrombin release an inhibitor of plasminogen activator (PAI), which has been shown previously to be neutralized by activated protein C (APC). The requirements for optimal neutralization of PAI activity were investigated. The releasate of gel-filtered human platelets stimulated with thrombin served as a source of PAI. When 6 X 10(8) platelets/mL were incubated with thrombin (1 IU/mL), the releasate contained 18 to 26 ng/mL PAI as determined by incubation of the releasate with urokinase and measurement of residual urokinase activity on plasminogen (S2251). Preincubation of PAI with up to 4 micrograms/mL APC for two hours yielded less than 20% neutralization of PAI activity. In the presence of protein S, phospholipid, and Ca2+, neutralization of PAI activity was time-dependent with 50% neutralization occurring in two hours with 1 microgram/mL APC. The cofactor effects of protein S and phospholipid were concentration-dependent with half-maximal acceleration at approximately 3 micrograms/mL protein S and 10 micrograms/mL phospholipid when the experiments were performed at 1 microgram/mL APC. Diisopropylfluorophosphate-inactivated APC, gla-domainless APC, and thrombin-cleaved protein S had no effect on PAI activity, indicating requirement for preservation of the APC active site and of the Ca2+ binding ability of both APC and protein S. These results suggest coordinate binding of APC and protein S onto phospholipid membrane as a prerequisite for optimal expression of PAI neutralized by APC.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2947643

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities.

Authors:  Angelina J Lay; Zhong Liang; Elliot D Rosen; Francis J Castellino
Journal:  J Clin Invest       Date:  2005-05-05       Impact factor: 14.808

2.  Free fatty acids inhibit TM-EPCR expression through JNK pathway: an implication for the development of the prothrombotic state in metabolic syndrome.

Authors:  Wanmu Xie; Zhenguo Zhai; Yuanhua Yang; Tuguang Kuang; Chen Wang
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

3.  Transgenic mice expressing recombinant human protein C exhibit defects in lactation and impaired mammary gland development.

Authors:  Carol A Palmer; Henryk Lubon; James L McManaman
Journal:  Transgenic Res       Date:  2003-06       Impact factor: 2.788

4.  Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.

Authors:  L R Jalbert; E D Rosen; L Moons; J C Chan; P Carmeliet; D Collen; F J Castellino
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

5.  Changes in the fibrinolytic system associated with physical conditioning.

Authors:  J A De Paz; J Lasierra; J G Villa; E Viladés; M A Martín-Nuño; J González-Gallego
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

6.  Portal vein thrombosis with ruptured oesophageal varices as presenting manifestation of hereditary protein C deficiency.

Authors:  D Valla; M H Denninger; J M Delvigne; B Rueff; J P Benhamou
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

Review 7.  Hemostatic changes in patients with brain tumors.

Authors:  L Thoron; E Arbit
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy.

Authors:  James E Campbell; Michael Adam Meledeo; Andrew P Cap
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.